Purchase Order HT001415P1526
Award Date 8/18/15
Potential Completion Date 8/24/15
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Valencia, CA 91355, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Health Agency awarded a Firm Fixed Price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V., for the FMRT-1-25-US AMNISURE ROM TEST. The $16,684.86 contract has an ultimate completion date of April 15, 2016. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has delivered a range of products and services to federal agencies through past prime and...
- The Defense Health Agency awarded a $39,540 firm fixed price purchase order to Qiagen, LLC on October 1, 2023, for the AMNISURE ROM TEST #FMRT-1-25-US contract. This procurement represents the utilization of unused Fiscal Year 2024 Defense Health Agency funds allocated to Contract Line Items 0001 and 0002. The contract is not associated with a set-aside designation, allowing Qiagen to compete in the open federal marketplace. The place of performance is located at Fort Johnson South, Louisiana,...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $92,270.00, is for the FMRT-1-25-US ROM TEST requirement and has an ultimate completion date of February 28, 2022. Qiagen, which has provided a range of products and services to federal agencies in the past, will deliver equipment, reagents, and testing services to support the DHA's biomedical...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Qiagen, LLC, a subsidiary of Qiagen N.V. The contract is for a standing order of 180 positive and negative controls and 24 Amnisure ROM tests, to be delivered in two equal shipments in October 2015 and April 2016. The contract also includes the use of the testing machine at no charge for one year, from October 1, 2015 to September 30, 2016. The total ceiling value...
- The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
- This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
- This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...
- This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
- This is a $14,500.00 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC. The contract is for an RT PCR System and does not have a set-aside designation. Qiagen, LLC is a subsidiary of the larger Qiagen N.V. corporation, an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has a history...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...